A Study to Investigate the Role of Noncoding RNA miR146 Alpha as a Potential Biomarker in Prostate Cancer
Keywords:Prostate Cancer, Non Coding RNA, miR146 alpha, Biomarker
There is a need for additional biomarkers for the diagnosis and prognosis of prostate cancer. MicroRNAs are a class of non-protein coding RNA molecules that are frequently dysregulated in different cancers including prostate cancer and show promise as diagnostic biomarkers and targets for therapy. Here we describe the role of micro RNA 146 a (miR-146a) which may serve as a diagnostic marker for prostate cancer, as indicated from the data presented in this report. Also, a pilot study indicated differential expression of miR-146a in prostate cancer cell lines and tissues from different racial groups. This report provides a novel insight into understanding the prostate carcinogenesis.
Chiam K, Ricciardelli C, Bianco-Miotto T. Epigenetic biomarkers in prostate cancer: Current and future uses. Cancer Letters 2014; 342(2): 248-56. https://doi.org/10.1016/j.canlet.2012.02.011 DOI: https://doi.org/10.1016/j.canlet.2012.02.011
Verma M. Genome-wide association studies and epigenome-wide association studies go together in cancer control. Future Oncol 2016; 12(13): 1645-64. https://doi.org/10.2217/fon-2015-0035 DOI: https://doi.org/10.2217/fon-2015-0035
Blute ML, Damaschke NA, Jarrard DF. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications. Curr Opin Urol 2015; 25(1): 83-8. https://doi.org/10.1097/MOU.0000000000000132 DOI: https://doi.org/10.1097/MOU.0000000000000132
Brothman AR, Swanson G, Maxwell TM, et al. Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome? Cancer Genet Cytogenet 2005; 156(1): 31-6. https://doi.org/10.1016/j.cancergencyto.2004.04.004 DOI: https://doi.org/10.1016/j.cancergencyto.2004.04.004
Sethi S, Kong D, Land S, et al. Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer. Am J Transl Res 2013; 5(2): 200-11.
Severi G, Southey MC, English DR, et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat 2014; 148(3): 665-73. https://doi.org/10.1007/s10549-014-3209-y DOI: https://doi.org/10.1007/s10549-014-3209-y
Shen J, LeFave C, Sirosh I, et al. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas. BMC Med Genomics 2015; 8: 28. https://doi.org/10.1186/s12920-015-0105-1 DOI: https://doi.org/10.1186/s12920-015-0105-1
Smolle M, Uranitsch S, Gerger A, et al. Current status of long noncoding RNAs in human cancer with specific focus on colorectal cancer. Int J Mol Sci 2014; 15(8): 13993-4013. https://doi.org/10.3390/ijms150813993 DOI: https://doi.org/10.3390/ijms150813993
Czajka AA, Wojcicka A, Kubiak A, et al. Family of microRNA146 Regulates RARbeta in Papillary Thyroid Carcinoma. PLoS One 2016; 11(3): e0151968. https://doi.org/10.1371/journal.pone.0151968 DOI: https://doi.org/10.1371/journal.pone.0151968
Li H, Xie S, Liu M, et al. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol 2014; 45(1): 197-208. https://doi.org/10.3892/ijo.2014.2415 DOI: https://doi.org/10.3892/ijo.2014.2415
Koppers-Lalic D, Hackenberg M, de Menezes R, et al. Bijnsdorp, Noninvasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles. Oncotarget 2016; 7(16): 22566-78. https://doi.org/10.18632/oncotarget.8124 DOI: https://doi.org/10.18632/oncotarget.8124
Kristensen H, Thomsen AR, Haldrup C, et al. Novel diagnostic and prognostic classifiers for prostate cancer identified by genomewide microRNA profiling. Oncotarget 2016; 7(21): 30760-71. https://doi.org/10.18632/oncotarget.8953 DOI: https://doi.org/10.18632/oncotarget.8953
Crea F, Venalainen E, Ci X, et al. The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer. Epigenomics 2016; 8(5): 721-31. https://doi.org/10.2217/epi.16.6 DOI: https://doi.org/10.2217/epi.16.6
Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 2015; 17(6): 816-26. https://doi.org/10.1038/ncb3169 DOI: https://doi.org/10.1038/ncb3169
Ye Y, Li SL, Ma YY, et al. Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer. Oncotarget 2017; 8(55): 94834-94849. https://doi.org/10.18632/oncotarget.22014 DOI: https://doi.org/10.18632/oncotarget.22014
Wotschofsky Z, Gummlich L, Liep J, et al. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p. PLoS One 2016; 11(2): e0148746. https://doi.org/10.1371/journal.pone.0148746 DOI: https://doi.org/10.1371/journal.pone.0148746
Li Z, Ma YY, Wang J, et al. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. Onco Targets Ther 2016; 9: 139-48. https://doi.org/10.2147/OTT.S95565 DOI: https://doi.org/10.2147/OTT.S95565
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.